2 Surging Stocks That You’ll Want to Think Twice About Buying Today
Stocks that quickly rise in value can seem like exciting ones to invest in. Taking advantage of the momentum can result in some great gains for investors. But when the fundamentals don’t support a …
Why Curaleaf Stock Surged 13% Higher Today
The Secure and Fair Enforcement Regulation (SAFER) Banking Act would allow cannabis businesses to access basic financial services; as the drug is illegal at the federal (if not necessarily the state) …
Why Did Tilray Stock Pop Today? – MSN
Tilray hasn’t earned a profit since 2018, back when marijuana stocks were still popular among momentum traders. It hasn’t generated positive free cash flow (FCF), well, ever.
10 Biggest Cannabis Stocks in the US and Canada
The cannabis market has faced unexpected challenges in 2025, despite initial optimism for rescheduling in the US. While US federal regulatory uncertainty and banking remain persistent, companies are …
Why Did Tilray Stock Pop Today?
Alliance Global Partners cut its price target on Tilray Brands ( TLRY 15.87%) stock by 25% this morning, from $1 to just $0.75 per share, as The Fly just reported. You’d probably expect news like that …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug. Read why I rate them as Buy.
Editorial: Is it finally time for legal marijuana in Pennsylvania?
President Donald Trump is mulling a move on marijuana. The president said Monday his administration was considering rescheduling the substance, moving it from Schedule I to a Schedule III. Scheduled …
If You’d Invested $1,000 in Trulieve Cannabis (TCNNF) 3 Years Ago, Here’s How Much You’d Have Today
The price nose-dived by nearly 40%, and it was hardly the worst performer among its peer group.
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification
Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift …
Up Around 40% in Just the Past Month, Could This Red-Hot Growth Stock Rally Even Higher?
One notable stock of late has been Tilray Brands ( TLRY -3.30%), which has a diverse business centering around cannabis and beverages. While it hasn’t been a strong buy at all this year (it’s down …
Global Legal Marijuana Market Expected to Reach 20–25% CAGR With Global Legal Expansion by 2029
The global legal marijuana market is set to witness a growth rate of 20-25% in the next 5 years. Increasing legalization of marijuana for medical and recreational use; growing awareness of medical …
Local marijuana grower to open two dispensaries in 2025
The team behind Forest Park-based marijuana grower King City Gardens plans to open multiple dispensaries in the region – starting with sites in Camp Washington and Sycamore Township that are slated to …
Cannabis shop owners sue Tri-Cities manager accused of stealing $700K
The Pacific Outpost owners are suing the Pasco cannabis shop’s former general manager for $770,000 she allegedly siphoned from the business in its first year.
Marijuana rescheduling still paused as Trump loyalists encourage action
The marijuana rescheduling process is still on hold, the U.S. Drug Enforcement Administration said in a quarterly update.
Recent Comments